FdaApplication
ANDA 202686
Identifiers
- fda_app_no: ANDA202686
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2017-05-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
| ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE;INTRAVENOUS |
2 products